Breast tissue testingAfter a person has been diagnosed with breast cancer, HER2/neu tissue testing is used to determine whether the tumor is positive for HER2/neu and the person may benefit from treatment with trastuzumab (Herceptin®), a drug that was created to target HER2.The American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) jointly recommend that the tumors of all people with invasive or recurrent breast cancer be tested for HER2/neu.Testing may also be used as a prognostic marker to help determine how aggressive the breast cancer tumor is likely to be. It is not diagnostic but helps to determine treatment options and understand more about the tumor's characteristics.HER2 testing is usually ordered along with estrogen and progesterone hormone receptor status tests (ER and PR). The results of these tests provide information about the person's likely prognosis and response to specific therapies, such as hormone therapy and chemotherapy.
Sample Type - Paraffin Blocks
Reporting Time - 9 Days
Prerequisites - No special preparation required
Price - ₹11980/-
Add to cart Go Home